New Oral Therapy Allows At-Home Treatment for Acute Myeloid Leukemia
A new oral therapy has been developed that enables older patients with acute myeloid leukemia to receive treatment at home, rather than requiring clinic visits for injections over five to seven consecutive days each month. Previously, AML treatment in older patients combined monthly clinic-based injections with oral medication, creating a burdensome treatment schedule. This development could significantly improve quality of life and treatment accessibility for elderly AML patients.
Acute myeloid leukemia is an aggressive blood and bone marrow cancer that has traditionally required intensive clinic-based treatment regimens for older patients. The standard approach involved monthly visits for intravenous injections administered over five to seven consecutive days, combined with oral medication taken at home. The introduction of an oral therapy that can replace the injection component represents a shift toward more convenient, at-home treatment options. This change addresses a significant burden on elderly patients who face logistical challenges with frequent clinic visits. The development could improve treatment adherence and quality of life for this patient population.
What's missing
The article does not specify the name of the new oral therapy, its efficacy data compared to standard treatment, approval status, or availability timeline.
What different sources said
- Medical XpressCenter
Oral therapy enables at-home treatment for acute myeloid leukemia
Related
New Research Advances Precision Targeting in Transcranial Magnetic Stimulation for Depression
Researchers have developed methods to fine-tune transcranial magnetic stimulation (TMS), a noninvasive treatment that uses magnetic pulses to stimulate neurons in depression patients. TMS has been used in psychiatry for years, but the new approach enables more precise targeting of specific symptoms. This advancement could lead to more personalized and effective mental health treatments.
Study Identifies Immune Biomarkers That May Predict Bladder Cancer Immunotherapy Response
A Northwestern Medicine study published in the Journal of Clinical Investigation has identified immune biomarkers that may help predict which bladder cancer patients will respond well to immunotherapy. The research addresses a significant clinical challenge: immunotherapy is effective for some patients but fails for others. These findings could help clinicians better select patients for immunotherapy and potentially improve treatment outcomes.
UK Veterinarians Call for Ban on Over-the-Counter Flea Treatments Due to Environmental Concerns
A panel of veterinarians told a UK House of Lords committee that over-the-counter flea treatments containing fipronil and imidacloprid should be banned, citing environmental toxicity to wildlife. The chemicals, already prohibited as agricultural pesticides in the UK, are found in most spot-on flea treatments and wash into waterways where they harm insects and aquatic ecosystems. The recommendation matters because it could reshape pet care practices and environmental protection policy, with 80% of British vets surveyed supporting a general sale ban.